melanoma

2:31
New models for patient care: advanced pharmacy practitioners
Dharmisha Chauhan
1:21
Treatment options for mucosal melanoma patients
Marcus Butler
3:35
KEYNOTE-006: the efficacy of ipilimumab after pembrolizumab in patients with advanced melanoma
Georgina Long
1:36
Preventing melanoma through public health education
Georgina Long
3:01
Oncolytic virus therapy in the treatment of melanoma
Kevin Harrington
2:58
Role of BRAF mutation in the treatment for melanoma
Dirk Schadendorf
5:40
Immunotherapy and targeted therapies for melanoma
Caroline Robert
2:12
Current clinical perspectives on targeted therapy and immunotherapy for melanoma
Caroline Robert
5:00
Clinical developments in the treatment for melanoma
Axel Hauschild
4:25
Aggressive care at the end-of-life for younger cancer patients: ASCO’s Choosing Wisely campaign
Ronald Chen
4:28
Global differences in cancer drug prices: a comparative analysis
Daniel Goldstein
6:11
Targeted therapy for advanced solid tumors based on molecular profiles: early results from MyPathway
John Hainsworth
2:01
CheckMate 172 trial of nivolumab for advanced melanoma: preliminary results
Paolo Ascierto
2:15
ASCO 2016 highlights for immunotherapy
Hendrik-Tobias Arkenau
1:48
Influence of new immunotherapy checkpoint inhibitors in melanoma
James Larkin
1:25
Targeting RAS oncogenes in patients with NRAS-mutated melanoma
Grant McArthur
VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJOncology is intended for healthcare professionals